🌟The Bright Side: Uganda declares end to 6th Ebola outbreak
The announcement came 42 days after the discharge of the last confirmed patient from hospital.
The outbreak marked the sixth time Uganda was affected by the deadly virus that has six different strains, three of which have caused major epidemics.
"During this outbreak, 14 cases, 12 confirmed and two not confirmed through laboratory tests (probable), were reported. Four deaths, two confirmed and two probable, occurred. Ten people recovered from the infection," The World Health Organization said in a statement.
The confirmed cases of the Sudan Ebola strain resulted in the death of a four-year-old child and a nurse.
Several dozens of people were also monitored after coming in contact with the disease, according to the African Union 's health agency (Africa CDC).
"The current Ebola Sudan Virus Disease outbreak has officially come to an end," Uganda's health ministry said on X.
"This follows 42 days without a new case since the last confirmed patient was discharged on March 14 2025."
World Health Organization chief Tedros Adhanom Ghebreyesus applauded the health ministry for its "leadership and commitment" in overcoming the outbreak.
"Congratulations to the government and health workers of #Uganda on ending the #Ebola outbreak," he said on X on Saturday.
There is currently no approved vaccine for the Ebola-Sudan strain.
But a vaccination trial for the strain was launched in the country in February. It was praised by the World Health Organization as the "fastest roll-out" of an Ebola vaccine trial in the midst of an epidemic.
But the international context for funding such health efforts is proving challenging.
In early March, the United Nations launched a call to raise $11.2 million to address this epidemic after the United States announced the cessation of most of its humanitarian aid.
Ebola is transmitted between people through body fluids. People who are infected do not become contagious until the appearance of symptoms – mainly fever, vomiting, bleeding and diarrhoea – which occur after an incubation period of between two and 21 days.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Euronews
10 hours ago
- Euronews
New malaria drug for newborns offers hope in Uganda
Alice Nekesa did not know she was infected with malaria-causing parasites until it was too late. She was in the fourth month of pregnancy last year when she started bleeding, a miscarriage later attributed to untreated malaria in her. The Ugandan farmer said recently that she regretted the loss of what would have been her second child 'because I didn't discover malaria and treat it early'. Variations of such cases are commonly reported by Ugandan health workers who witness stillbirths or feverish babies that die within days from undiagnosed malaria. The deaths are part of a wider death toll tied to the mosquito-borne disease, the deadliest across Africa, but one easily treated in adults who seek timely medical care. Until recently, a major gap in malaria treatment was how to care for newborns and infants infected with malaria who weren't strong enough to receive regular medication. That changed last month when Swiss medical regulators approved medicine from the Basel-based pharmaceutical company Novartis for babies weighing between 2 and 5 kilograms (about two to five kilograms). Swissmedic said the treatment, a sweet-tasting tablet that dissolves into a syrup when dropped into liquids like breast milk, was approved in coordination with the World Health Organization (WHO) under a fast-track authorisation process to help developing countries access much-needed treatment. Africa's 1.5 billion people accounted for 95 per cent of an estimated 597,000 malaria deaths worldwide in 2023, according to the WHO. More than three-quarters of those deaths were among children. In Uganda, an east African country of 45 million people, there were 12.6 million malaria cases and nearly 16,000 deaths in 2023. Many were children younger than five and pregnant women, the WHO said. Nigeria, Congo, and Uganda – in that order – are the African countries most burdened by malaria, a parasitic disease transmitted to humans through the bites of infected mosquitoes that thrive and breed in stagnant water. The drug approved by Swiss authorities, known as Coartem Baby in some countries and Riamet Baby in others, is a combination of two antimalarials. It is a lower dose version of a tablet previously approved for other age groups, including for older children. Before Coartem Baby, antimalarial drugs designed for older children were administered to small infants with careful adjustments to avoid overdose or toxicity. Ugandan authorities, who have been working to update clinical guidelines for treating malaria, say the new drug will be rolled out as soon as possible. It is not yet available in public hospitals. How the medicine could change malaria treatment The development of Coartem Baby has given hope to many, with local health workers and others saying the medicine will save the lives of many infants. Ronald Serufusa, the top malaria official for the district of Wakiso, which shares a border with the Ugandan capital of Kampala, said he believes Coartem Baby will be available 'very, very soon' and that one priority is sensitising the people adhering to treatment. Some private pharmacies already have access to Coartem Baby, 'flavored with orange or mango' to make it palatable for infants, he said. During the so-called malaria season, which coincides with rainy periods twice a year, long lines of sick patients grow outside government-run health centres across Uganda. Many are often women with babies strapped to their backs. Health workers now are trained to understand that 'malaria can be implicated among newborns,' even when other dangerous conditions like sepsis are present, Serufusa said. 'If they don't expand their investigations to also suspect malaria, then it goes unnoticed,' he said, speaking of health workers treating babies. The Malaria Consortium, a global nonprofit based in London, in a statement described the approval of Coartem Baby as 'a major leap forward for saving the lives of young children in countries affected by malaria'. In addition to Uganda, the drug will be rolled out in Burkina Faso, Côte d'Ivoire, Kenya, Malawi, Mozambique, Nigeria, and Tanzania, the group said. Jane Nabakooza, a pediatrician with Uganda's malaria control programme, said she expects the government will make Coartem Baby available to patients free of charge, even after losing funding when the United States shrank its foreign aid programme earlier this year. Some malaria funding from outside sources, including the Global Fund to Fight AIDS, Malaria and Tuberculosis, remains available for programmes such as indoor spraying to kill mosquitoes that spread the malaria-causing parasite. Because of funding shortages, 'we are focusing on those that are actually prone to severe forms of malaria and malaria deaths, and these are children under five years,' Nabakooza said.
Euronews
a day ago
- Euronews
New malaria drug for newborns offers in Uganda
Alice Nekesa did not know she was infected with malaria-causing parasites until it was too late. She was in the fourth month of pregnancy last year when she started bleeding, a miscarriage later attributed to untreated malaria in her. The Ugandan farmer said recently that she regretted the loss of what would have been her second child 'because I didn't discover malaria and treat it early'. Variations of such cases are commonly reported by Ugandan health workers who witness stillbirths or feverish babies that die within days from undiagnosed malaria. The deaths are part of a wider death toll tied to the mosquito-borne disease, the deadliest across Africa, but one easily treated in adults who seek timely medical care. Until recently, a major gap in malaria treatment was how to care for newborns and infants infected with malaria who weren't strong enough to receive regular medication. That changed last month when Swiss medical regulators approved medicine from the Basel-based pharmaceutical company Novartis for babies weighing between 2 and 5 kilograms (about two to five kilograms). Swissmedic said the treatment, a sweet-tasting tablet that dissolves into a syrup when dropped into liquids like breast milk, was approved in coordination with the World Health Organization (WHO) under a fast-track authorisation process to help developing countries access much-needed treatment. Africa's 1.5 billion people accounted for 95 per cent of an estimated 597,000 malaria deaths worldwide in 2023, according to the WHO. More than three-quarters of those deaths were among children. In Uganda, an east African country of 45 million people, there were 12.6 million malaria cases and nearly 16,000 deaths in 2023. Many were children younger than five and pregnant women, the WHO said. Nigeria, Congo, and Uganda – in that order – are the African countries most burdened by malaria, a parasitic disease transmitted to humans through the bites of infected mosquitoes that thrive and breed in stagnant water. The drug approved by Swiss authorities, known as Coartem Baby in some countries and Riamet Baby in others, is a combination of two antimalarials. It is a lower dose version of a tablet previously approved for other age groups, including for older children. Before Coartem Baby, antimalarial drugs designed for older children were administered to small infants with careful adjustments to avoid overdose or toxicity. Ugandan authorities, who have been working to update clinical guidelines for treating malaria, say the new drug will be rolled out as soon as possible. It is not yet available in public hospitals. How the medicine could change malaria treatment The development of Coartem Baby has given hope to many, with local health workers and others saying the medicine will save the lives of many infants. Ronald Serufusa, the top malaria official for the district of Wakiso, which shares a border with the Ugandan capital of Kampala, said he believes Coartem Baby will be available 'very, very soon' and that one priority is sensitising the people adhering to treatment. Some private pharmacies already have access to Coartem Baby, 'flavored with orange or mango' to make it palatable for infants, he said. During the so-called malaria season, which coincides with rainy periods twice a year, long lines of sick patients grow outside government-run health centres across Uganda. Many are often women with babies strapped to their backs. Health workers now are trained to understand that 'malaria can be implicated among newborns,' even when other dangerous conditions like sepsis are present, Serufusa said. 'If they don't expand their investigations to also suspect malaria, then it goes unnoticed,' he said, speaking of health workers treating babies. The Malaria Consortium, a global nonprofit based in London, in a statement described the approval of Coartem Baby as 'a major leap forward for saving the lives of young children in countries affected by malaria'. In addition to Uganda, the drug will be rolled out in Burkina Faso, Côte d'Ivoire, Kenya, Malawi, Mozambique, Nigeria, and Tanzania, the group said. Jane Nabakooza, a pediatrician with Uganda's malaria control programme, said she expects the government will make Coartem Baby available to patients free of charge, even after losing funding when the United States shrank its foreign aid programme earlier this year. Some malaria funding from outside sources, including the Global Fund to Fight AIDS, Malaria and Tuberculosis, remains available for programmes such as indoor spraying to kill mosquitoes that spread the malaria-causing parasite. Because of funding shortages, 'we are focusing on those that are actually prone to severe forms of malaria and malaria deaths, and these are children under five years,' Nabakooza said.
France 24
3 days ago
- France 24
UN says record 383 aid workers killed in 2024
The 2024 figure was up 31 percent on the year before, the UN said on World Humanitarian Day, "driven by the relentless conflicts in Gaza, where 181 humanitarian workers were killed, and in Sudan, where 60 lost their lives". It said state actors were the most common perpetrators of the killings in 2024. The UN said most of those killed were local staff, and were either attacked in the line of duty or in their homes. Besides those killed, 308 aid workers were wounded, 125 kidnapped and 45 detained last year. "Even one attack against a humanitarian colleague is an attack on all of us and on the people we serve," said UN aid chief Tom Fletcher. "Attacks on this scale, with zero accountability, are a shameful indictment of international inaction and apathy. "As the humanitarian community, we demand -- again -- that those with power and influence act for humanity, protect civilians and aid workers and hold perpetrators to account." Provisional figures from the Aid Worker Security Database show that 265 aid workers have been killed this year, as of August 14. The UN reiterated that attacks on aid workers and operations violate international humanitarian law and damage the lifelines sustaining millions of people trapped in war and disaster zones. "Violence against aid workers is not inevitable. It must end," said Fletcher, the UN emergency relief coordinator and under-secretary-general for humanitarian affairs. Meanwhile the UN's World Health Organization said it had verified more than 800 attacks on health care in 16 territories so far this year, with more than 1,110 health workers and patients killed and hundreds injured. "Each attack inflicts lasting harm, deprives entire communities of life-saving care when they need it the most, endangers health care providers, and weakens already strained health systems," the WHO said. World Humanitarian Day marks the day in 2003 when UN rights chief Sergio Vieira de Mello and 21 other humanitarians were killed in the bombing of the UN headquarters in Baghdad.
